GB0905670D0 - Compounds for treatment of duchenne muscular dystrophy - Google Patents
Compounds for treatment of duchenne muscular dystrophyInfo
- Publication number
- GB0905670D0 GB0905670D0 GBGB0905670.6A GB0905670A GB0905670D0 GB 0905670 D0 GB0905670 D0 GB 0905670D0 GB 0905670 A GB0905670 A GB 0905670A GB 0905670 D0 GB0905670 D0 GB 0905670D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- treatment
- muscular dystrophy
- duchenne muscular
- duchenne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0905670.6A GB0905670D0 (en) | 2009-04-02 | 2009-04-02 | Compounds for treatment of duchenne muscular dystrophy |
PCT/EP2009/065128 WO2010112092A1 (en) | 2009-04-02 | 2009-11-13 | Compounds for treatment of duchenne musculary dystrophy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0905670.6A GB0905670D0 (en) | 2009-04-02 | 2009-04-02 | Compounds for treatment of duchenne muscular dystrophy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0905670D0 true GB0905670D0 (en) | 2009-05-20 |
Family
ID=40749944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0905670.6A Ceased GB0905670D0 (en) | 2009-04-02 | 2009-04-02 | Compounds for treatment of duchenne muscular dystrophy |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0905670D0 (en) |
WO (1) | WO2010112092A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201412010D0 (en) | 2014-07-04 | 2014-08-20 | Summit Corp Plc | Treatment of hypertransaminasemia |
KR20230063915A (en) * | 2021-10-29 | 2023-05-10 | 중앙대학교 산학협력단 | Composition for preventing, improving or treating muscular dystrophy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000108513A (en) * | 1998-10-05 | 2000-04-18 | Mitsui Chemicals Inc | Photorecording medium |
GB0715939D0 (en) * | 2007-08-15 | 2007-09-26 | Vastox Plc | Method of treatment of duchenne muscular dystrophy |
-
2009
- 2009-04-02 GB GBGB0905670.6A patent/GB0905670D0/en not_active Ceased
- 2009-11-13 WO PCT/EP2009/065128 patent/WO2010112092A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010112092A1 (en) | 2010-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0815369D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
GB0821307D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
GB0822981D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
GB0715938D0 (en) | Method of treatment of duchenne muscular dystrophy | |
IL228598A0 (en) | Treatment of duchenne muscular dystrophy | |
PL2170396T3 (en) | Drug combinations for the treatment of duchenne muscular dystrophy | |
GB0715087D0 (en) | Drug combinations for the treatment of duchenne muscular dystrophy | |
IL193314A0 (en) | Treatment of duchenne muscular dystrophy | |
ME02347B (en) | Rostafuroxine for pharmacogenomic treatment of cardiovascular conditions | |
ZA200806986B (en) | Treatment of duchenne muscular dystrophy | |
GB0715939D0 (en) | Method of treatment of duchenne muscular dystrophy | |
EP2576582A4 (en) | Treatment of muscular dystrophy | |
GB0905664D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
GB0905670D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
GB0905667D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
HK1178057A1 (en) | Treatment of osteoporosis | |
GB0809314D0 (en) | Compounds for treating muscular dystrophy | |
GB0901417D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
GB0902411D0 (en) | Compounds for treatment of duchenne muscular dystrophy | |
GB0901794D0 (en) | Compounds for treating muscular dystrophy | |
GB0803906D0 (en) | Compounds for treating duchenne muscular dystrophy | |
GB0807216D0 (en) | Drug combination for the treatment of duchenne muscular dystrophy | |
GB0913427D0 (en) | Compounds for treatment of imflammation | |
EG26997A (en) | Tube for treatment of syrngomylia | |
GB0623985D0 (en) | Treatment of duchenne muscular dystrophy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |